Advertisement
News
Advertisement

Nuclea Biotechnologies lands $3M funding

Thu, 08/18/2011 - 8:37pm
Mass High Tech: The Journal of New England Technology

Nuclea Biotechnologies LLC, a cancer diagnostics firm in Pittsfield, has rounded up $3 million in an equity offering backed by 28 investors, the company noted in a regulatory filing today.

The filing with the U.S. Securities and Exchange Commission did not disclose the names of the investors.

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading